Abstract
Background:
Labor is a naturally occurring physiological process
associated with uterine contractions, effacement,
dilatation of cervix and descent of presenting part.
Drotaverine hydrochloride is a non-anticholinergic iso-
quinoline derivative which acts by elevating intracellular
cyclic Adenosine Mono Phosphate (cAMP) and cyclic
Guanosine Mono Phosphate (cGMP) promoting smooth
muscle relaxation.
Materials And Method: This was
a hospital based prospective study on effectiveness of
Drotaverine Hydrochloride on enhancing dilatation of
cervix and acceleration of active phase of labor. The
sample size was 100. Fifty cases of women in active phase
of labor received injection drotaverine hydrochloride 40
mg (group i) and fifty cases of women did not receive
any drug (group ii) among those at term with singleton
pregnancy and vertex presentation. Variables like
maternal age, interval between administration of drug
and delivery, mode of delivery, apgar score at 5 minutes,
NCU (Neonatal Care Unit) admission and neonatal
outcomes were recorded. Data analysis was done with
the help of SPSS program.
Results: The mean interval
between drug adminstration to delivery in primipara and
multipara in group i was 3.05 hours and 2.31 hours while
in group ii was 4.5 hours and 3.75 hours respectively. The
mean interval between drug adminstration and delivery was
shorter in both groups of multipara. In group i, 96% had
normal delivery and 4 % had vaccum delivery and in group
ii 90% and 10% had normal delivery and vacuum delivery
respectively. None of the participants had caeseraian
section. There were no perinatal mortalities.
Conclusion:
The administration of drug Drotaverine Hydrochloride is
effective in shortening duration of labor with favorable
feto-maternal outcome.
References
Bairwa R, Songara RK. Significant combination
of preferential cox-2 inhibitor and non-
anticholinergic spasmolytic used in labor
augmentation. Pharmacologyonline 2011;2:470-
476.
2. Tripathi KD. Antichoinergic drug and drug acting
on autonomic gangalia. Essential of medical
pharmacology. 6th ed. Jaypee brother’s medical
publishers Ltd. New Delhi 2008; p.111-12.
3. Sharma JB, PundirP, Kumar A, Murthy NS.
Drotaverine hydrochloride vsvalethamate
bromide in acceleration of labor. Int Journal of
Gynaecology& Obstetrics 2001;74:255-260.
4. NaqviSB, HaroonZUN. Efficacy and safety of
drotaverine and phloroglucinol in first stage of
labor. Pak J Surg 2011;27(1):39-43.
5. O Dricoll K, Stronge JM, Minogue M. Active
management of labor. Br Med J 1973; 3:135-137.
6. Ashok KB In search of efficacy of valethamate
bromide, a cervical dilator: review of global
medicine and healthcare research (RGMHR)
2011; 2(1):17-21.
7. Singh KC, Jain P, Goel N, Saxena A. Drotaverine
hydrochloride for augmentation of labour. Int J
GynaecolObstet 2004; 84:17-22.
8. Thapa M, Saha R, Pradhan A, Shrestha S. Effect
of drotaverine hydrochloride in progress of labor.
Nepal J ObstetGynaecol 2007Nov-Dec; 2(2):9-
11.
9. Yuel V I, Kaur V, Kaur D. Programmed labor for
optimizing labor and delivery. JK Science 2008
April-June; 10(2):62-64.
10. Majumder S, Ray J, Baidya ,Rakshit A, Kumar SN.
Comparative study of drotaverine hydrochloride
and valethamate bromide in active management
of labor. Journal OfPaediatricsObstetrice and
Gynaecology 2010 November; 1(11):416-420.
11. Tripti N, Jyoti J. To compare and evaluate
the efficacy and safety of drotaverine and
valethamatebromidae. J ObstetGynecol India
2009; 54:324-331.
12. Mercer BM, McNanley T, O’ Brien JM, Randal
L, Sibai BM. Early versus late amniotomy
for labor induction: a randomized trial. Am J
ObstetGynecol 1995; 173(4):1321-1325.
13. Gupta B, Neelone V, Mittal S. Drotaverine
hydrochloride versus Hyoscine-N-butylbromide
in augentaton of labor. International Journal of
Gynecology and Obstetrics 2008; 100:244-247.